THINK Surgical’s TMINI Miniature Robotic System has been used in its 5,000th total knee replacement procedure.
This announcement comes just one year after the 1,000th case milestone, as adoption of the TMINI System continues to grow across the U.S. thanks to THINK’s dual channel commercial strategy. Zimmer Biomet’s exclusive distribution partnership continues to draw interest with the TMINI System and the Persona Knee System combination. The open platform TMINI System offering surgeon and facility choice has also recently expanded its implant compatibility with the announcement of compatibility with the Stryker Triathlon Knee in February 2026.
The additional implant compatibility brings the total U.S. market coverage of the TMINI Miniature Robotic System by implant volume to approximately 70%.
“This procedure milestone demonstrates a fivefold increase in case volume over the last 12 months,” said Stuart Simpson, President and Chief Executive Officer of THINK Surgical. “The addition of new implant modules on our open-platform TMINI and acceleration in the exclusive distribution partnership with Zimmer Biomet are both driving this growth.”
THINK Surgical's TMINI Miniature Robotic System has been used in its 5,000th total knee replacement procedure.
This announcement comes just one year after the 1,000th case milestone, as adoption of the TMINI System continues to grow across the U.S. thanks to THINK's dual channel commercial strategy. Zimmer Biomet's exclusive...
THINK Surgical’s TMINI Miniature Robotic System has been used in its 5,000th total knee replacement procedure.
This announcement comes just one year after the 1,000th case milestone, as adoption of the TMINI System continues to grow across the U.S. thanks to THINK’s dual channel commercial strategy. Zimmer Biomet’s exclusive distribution partnership continues to draw interest with the TMINI System and the Persona Knee System combination. The open platform TMINI System offering surgeon and facility choice has also recently expanded its implant compatibility with the announcement of compatibility with the Stryker Triathlon Knee in February 2026.
The additional implant compatibility brings the total U.S. market coverage of the TMINI Miniature Robotic System by implant volume to approximately 70%.
“This procedure milestone demonstrates a fivefold increase in case volume over the last 12 months,” said Stuart Simpson, President and Chief Executive Officer of THINK Surgical. “The addition of new implant modules on our open-platform TMINI and acceleration in the exclusive distribution partnership with Zimmer Biomet are both driving this growth.”
Copy to clipboard 
